<DOC>
	<DOCNO>NCT00704314</DOCNO>
	<brief_summary>We aim address issue whether statin affect insulin resistance . To end , combine available state-of-the art technology detailed assessment whole-body tissue specific insulin sensitivity vivo human ( euglycemic-hyperinsulinemic clamp , stable isotope [ 6,6-2H2 ] glucose dilution technique , proton nuclear magnetic resonance spectroscopy - 1H MRS - liver skeletal muscle ) . Outcome measure determine 8 week therapy 80 mg Simvastatin hypercholesterolemic patient type 2 diabetes .</brief_summary>
	<brief_title>Does Simvastatin Affect Insulin Sensitivity Dyslipidemic Type 2 Diabetic Patients ?</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Type 2 diabetic patient know duration disease : 310 year Age : 3575 year BMI &lt; 32 kg/m2 Hypercholesterolemia : fast serum low density lipoprotein ( LDL ) Cholesterol concentration &lt; 4.16 mmol/L ( &lt; 160 mg/dl ) Normotriglyceridemia : fasting plasma triglyceride concentration &lt; 2.75 mmol/L ( 250 mg/dl ) Creatinine level &lt; 1.8 mg /dl Liver transaminases &lt; 20 % upper limit active liver disease CK &lt; 50 % upper limit Blood pressure le 160/100 mmHg accept eligible enrollment Hypertension , cardiovascular disease metabolic diseases T2DM determine medical history , physical examination routine laboratory test Alcohol consumption ( 10 drinks/week ) Poor glycemic control ( HbA1c &lt; 9 % ) Patients require insulin , patient type 1 diabetes Patients take medicine know interfere metabolism statins insulin sensitivity summarize exclusionary drug table Patients receive hypolipidemic medication diet last 2 month enrollment</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Insulin resistance</keyword>
	<keyword>Statins</keyword>
	<keyword>Muscle liver triglyceride</keyword>
</DOC>